Cleopatra Hospital Group S.A.E. operates hospitals in Egypt.
No risks detected for CLHO from our risk checks.
Cleopatra Hospital GroupE Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||ج.م4.29|
|52 Week High||ج.م3.70|
|52 Week Low||ج.م5.62|
|1 Month Change||-4.67%|
|3 Month Change||-6.74%|
|1 Year Change||-14.37%|
|3 Year Change||18.18%|
|5 Year Change||-55.64%|
|Change since IPO||-55.59%|
Recent News & Updates
|CLHO||EG Healthcare||EG Market|
Return vs Industry: CLHO exceeded the EG Healthcare industry which returned -16.1% over the past year.
Return vs Market: CLHO underperformed the EG Market which returned 9.6% over the past year.
Stable Share Price: CLHO is not significantly more volatile than the rest of EG stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: CLHO's weekly volatility (5%) has been stable over the past year.
About the Company
|1984||4,284||Ahmed Ezzeldin Abdelaal||https://www.cleopatrahospitals.com|
Cleopatra Hospital Group S.A.E. operates hospitals in Egypt. The company’s hospitals provide an array of general and emergency healthcare services in the areas of cardiology, radiology, orthopedic, urology, and others. It also offers various medical services, such as surgeries, admission, medical supervision, laboratory, tests, and outpatient clinic services; and telemedicine services, including digital consultation and follow up appointments.
Cleopatra Hospital GroupE Fundamentals Summary
|CLHO fundamental statistics|
Is CLHO overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|CLHO income statement (TTM)|
|Cost of Revenue||ج.م1.52b|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
|Earnings per share (EPS)||0.20|
|Net Profit Margin||13.21%|
How did CLHO perform over the long term?See historical performance and comparison
Is Cleopatra Hospital GroupE undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: CLHO (EGP4.29) is trading above our estimate of fair value (EGP2.68)
Significantly Below Fair Value: CLHO is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: CLHO is good value based on its PE Ratio (21.5x) compared to the African Healthcare industry average (32.3x).
PE vs Market: CLHO is poor value based on its PE Ratio (21.5x) compared to the EG market (11.8x).
Price to Earnings Growth Ratio
PEG Ratio: CLHO is poor value based on its PEG Ratio (1.1x)
Price to Book Ratio
PB vs Industry: CLHO is overvalued based on its PB Ratio (3.2x) compared to the XF Healthcare industry average (2.8x).
How is Cleopatra Hospital GroupE forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CLHO's forecast earnings growth (19.3% per year) is above the savings rate (9.1%).
Earnings vs Market: CLHO's earnings (19.3% per year) are forecast to grow faster than the EG market (14.4% per year).
High Growth Earnings: CLHO's earnings are forecast to grow, but not significantly.
Revenue vs Market: CLHO's revenue (13.4% per year) is forecast to grow faster than the EG market (10% per year).
High Growth Revenue: CLHO's revenue (13.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CLHO's Return on Equity is forecast to be low in 3 years time (19.3%).
How has Cleopatra Hospital GroupE performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: CLHO has high quality earnings.
Growing Profit Margin: CLHO's current net profit margins (13.2%) are higher than last year (11.8%).
Past Earnings Growth Analysis
Earnings Trend: CLHO's earnings have grown significantly by 25.9% per year over the past 5 years.
Accelerating Growth: CLHO's earnings growth over the past year (48.7%) exceeds its 5-year average (25.9% per year).
Earnings vs Industry: CLHO earnings growth over the past year (48.7%) exceeded the Healthcare industry 4.5%.
Return on Equity
High ROE: CLHO's Return on Equity (17.9%) is considered low.
How is Cleopatra Hospital GroupE's financial position?
Financial Position Analysis
Short Term Liabilities: CLHO's short term assets (EGP1.3B) exceed its short term liabilities (EGP687.0M).
Long Term Liabilities: CLHO's short term assets (EGP1.3B) exceed its long term liabilities (EGP299.1M).
Debt to Equity History and Analysis
Debt Level: CLHO's debt to equity ratio (6.2%) is considered satisfactory.
Reducing Debt: CLHO's debt to equity ratio has reduced from 184.6% to 6.2% over the past 5 years.
Debt Coverage: CLHO's debt is well covered by operating cash flow (386.7%).
Interest Coverage: CLHO earns more interest than it pays, so coverage of interest payments is not a concern.
What is Cleopatra Hospital GroupE current dividend yield, its reliability and sustainability?
Forecast Dividend Yield
Dividend Yield vs Market
Notable Dividend: Unable to evaluate CLHO's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate CLHO's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if CLHO's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if CLHO's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of CLHO's dividend in 3 years as they are not forecast to pay a notable one for the EG market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Ahmed Ezzeldin Abdelaal
Dr. Ahmed Ezzeldin Mahmoud Abdelaal serves as Group Chief Executive Officer, Managing Director and Director at Cleopatra Hospital Company S.A.E. and also served as its Chairman. Dr. Abdelaal joined Cleopat...
Experienced Management: CLHO's management team is considered experienced (2.8 years average tenure).
Experienced Board: CLHO's board of directors are not considered experienced ( 2 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Cleopatra Hospital Group S.A.E.'s employee growth, exchange listings and data sources
- Name: Cleopatra Hospital Group S.A.E.
- Ticker: CLHO
- Exchange: CASE
- Founded: 1984
- Industry: Health Care Facilities
- Sector: Healthcare
- Market Cap: ج.م6.800b
- Shares outstanding: 1.60b
- Website: https://www.cleopatrahospitals.com
Number of Employees
- Cleopatra Hospital Group S.A.E.
- 4 El saada Street
- Zahraa El Maadi beside Carrefour
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/10/20 15:33|
|End of Day Share Price||2021/10/20 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.